Koshinski Asset Management’s AbbVie ABBV Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $8.72M | Buy |
34,655
+586
| +2% | +$126K | 0.46% | 47 |
|
|
2026
Q1 | $7.41M | Buy |
34,069
+80
| +0.2% | +$17.7K | 0.46% | 48 |
|
|
2025
Q4 | $7.77M | Sell |
33,989
-232
| -0.7% | -$52.9K | 0.5% | 44 |
|
|
2025
Q3 | $7.92M | Buy |
34,221
+1,193
| +4% | +$243K | 0.53% | 39 |
|
|
2025
Q2 | $6.13M | Sell |
33,028
-481
| -1% | -$89.4K | 0.46% | 40 |
|
|
2025
Q1 | $7.02M | Buy |
33,509
+704
| +2% | +$137K | 0.6% | 31 |
|
|
2024
Q4 | $5.83B | Sell |
32,805
-454
| -1% | -$83.5K | 0.5% | 38 |
|
|
2024
Q3 | $6.57M | Sell |
33,259
-1,040
| -3% | -$194K | 0.57% | 30 |
|
|
2024
Q2 | $5.76M | Buy |
34,299
+579
| +2% | +$95.9K | 0.53% | 35 |
|
|
2024
Q1 | $6.14M | Buy |
33,720
+4,235
| +14% | +$730K | 0.63% | 27 |
|
|
2023
Q4 | $4.57M | Sell |
29,485
-5,415
| -16% | -$789K | 0.69% | 28 |
|
|
2023
Q3 | $5.2M | Sell |
34,900
-58
| -0.2% | -$8.52K | 0.6% | 30 |
|
|
2023
Q2 | $4.71M | Sell |
34,958
-10,618
| -23% | -$1.56M | 0.5% | 35 |
|
|
2023
Q1 | $7.26M | Sell |
45,576
-535
| -1% | -$81.8K | 0.71% | 25 |
|
|
2022
Q4 | $7.45M | Buy |
46,111
+339
| +0.7% | +$52K | 0.72% | 23 |
|
|
2022
Q3 | $6.14M | Buy |
45,772
+147
| +0.3% | +$21.1K | 0.73% | 22 |
|
|
2022
Q2 | $6.99M | Sell |
45,625
-19,011
| -29% | -$2.9M | 0.69% | 23 |
|
|
2022
Q1 | $10.5M | Sell |
64,636
-447
| -0.7% | -$64.9K | 0.86% | 18 |
|
|
2021
Q4 | $8.81M | Buy |
65,083
+1,114
| +2% | +$132K | 0.71% | 20 |
|
|
2021
Q3 | $6.9M | Buy |
63,969
+11,717
| +22% | +$1.34M | 0.6% | 25 |
|
|
2021
Q2 | $5.89M | Sell |
52,252
-17,432
| -25% | -$1.96M | 0.74% | 23 |
|
|
2021
Q1 | $7.54M | Sell |
69,684
-53,838
| -44% | -$5.76M | 0.8% | 21 |
|
|
2020
Q4 | $13.2M | Buy |
123,522
+65,084
| +111% | +$6.25M | 1.68% | 6 |
|
|
2020
Q3 | $5.16K | Sell |
58,438
-1,585
| -3% | -$149K | 0.69% | 28 |
|
|
2020
Q2 | $5.89M | Buy |
60,023
+3,916
| +7% | +$345K | 0.96% | 16 |
|
|
2020
Q1 | $4.28M | Buy |
56,107
+15,298
| +37% | +$1.3M | 0.9% | 19 |
|
|
2019
Q4 | $3.61M | Buy |
+40,809
| New | +$3.39M | 0.62% | 30 |
|
|
2019
Q2 | – | Sell |
-18,668
| Closed | -$1.5K | – | 272 |
|
|
2019
Q1 | $1.5K | Sell |
18,668
-5,649
| -23% | -$462K | 0.4% | 66 |
|
|
2018
Q4 | $2.24M | Sell |
24,317
-21,297
| -47% | -$1.87M | 0.55% | 55 |
|
|
2018
Q3 | $4.31M | Buy |
45,614
+29,995
| +192% | +$2.84M | 0.61% | 34 |
|
|
2018
Q2 | $1.45M | Sell |
15,619
-230
| -1% | -$22.5K | 0.44% | 66 |
|
|
2018
Q1 | $1.5M | Sell |
15,849
-16,487
| -51% | -$1.81M | 0.47% | 59 |
|
|
2017
Q4 | $3.13M | Buy |
32,336
+19,762
| +157% | +$1.86M | 0.78% | 11 |
|
|
2017
Q3 | $1.12M | Buy |
12,574
+804
| +7% | +$61.2K | 0.37% | 86 |
|
|
2017
Q2 | $853K | Buy |
11,770
+2,586
| +28% | +$174K | 0.31% | 105 |
|
|
2017
Q1 | $598K | Buy |
9,184
+773
| +9% | +$48.6K | 0.23% | 133 |
|
|
2016
Q4 | $527K | Sell |
8,411
-1,689
| -17% | -$103K | 0.26% | 130 |
|
|
2016
Q3 | $637K | Sell |
10,100
-39
| -0.4% | -$2.52K | 0.32% | 106 |
|
|
2016
Q2 | $628K | Buy |
10,139
+2,178
| +27% | +$133K | 0.34% | 106 |
|
|
2016
Q1 | $455K | Buy |
7,961
+461
| +6% | +$25.7K | 0.29% | 118 |
|
|
2015
Q4 | $444K | Sell |
7,500
-478
| -6% | -$27.5K | 0.31% | 103 |
|
|
2015
Q3 | $536K | Sell |
7,978
-288
| -3% | -$18.7K | 0.34% | 90 |
|
|
2015
Q2 | $555K | Buy |
8,266
+1,403
| +20% | +$91.6K | 0.35% | 88 |
|
|
2015
Q1 | $402K | Sell |
6,863
-525
| -7% | -$31.7K | 0.26% | 112 |
|
|
2014
Q4 | $483K | Buy |
+7,388
| New | +$466K | 0.27% | 98 |
|
Other funds holding ABBV
Koshinski Asset Management's ABBV Position: Q2 2026 in Review
Koshinski Asset Management increased its AbbVie (ABBV) stake by 1.7% in Q2 2026, buying an estimated $126K and bringing the position to 34,655 shares worth $8.72M. The position accounts for 0.46% of the portfolio, ranked #47.
Koshinski Asset Management first reported a position in ABBV in Q4 2014 and has held it in 45 quarters since. The position peaked at $5.83B in Q4 2024. 4,193 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.
- Koshinski Asset Management held 34,655 shares of AbbVie worth $8.72M as of Q2 2026.
- Koshinski Asset Management bought 586 AbbVie shares in Q2 2026, an estimated $126K.
- AbbVie made up 0.46% of Koshinski Asset Management's portfolio in Q2 2026, its #47 holding.
- Koshinski Asset Management first reported a position in AbbVie in Q4 2014 and has held it in 45 quarters since.
- Koshinski Asset Management's AbbVie position peaked at $5.83B in Q4 2024.
- 4,193 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.
Based on Koshinski Asset Management's 13F filing for Q2 2026, filed 27 Jul 2026.